ERBB2 and cancer: Patients with ER positive cancer will be offered endocrine therapy: tamoxifen if premenopausal and aromatase inhibitors if postmenopausal (8), while HER2 positive tumors will be treated by biologic therapies involving monoclonal antibodies (9).